Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 430,708 | 481,147 | 340,450 | N/A | 418,163 |
| TOTAL | $445,352 | $487,822 | $346,791 | $N/A | $424,454 |
| Non-Current Assets | |||||
| PPE Net | 234 | 101 | 46 | N/A | 122 |
| Intangibles | 542 | 486 | 170 | 0 | 89,008 |
| Other Non-Current Assets | 562 | 54 | 90 | 0 | 101 |
| TOTAL | $1,338 | $641 | $306 | $N/A | $89,232 |
| Total Assets | $446,690 | $488,463 | $347,097 | $N/A | $513,685 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,275 | 8,536 | 16,923 | 0 | 22,739 |
| Accrued Expenses | 10,194 | 9,970 | 11,398 | N/A | N/A |
| Other current liabilities | 23,545 | 33,061 | 12,574 | N/A | 8,426 |
| TOTAL | $45,307 | $59,726 | $49,897 | $N/A | $41,801 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,059 | 8,116 | 8,942 | N/A | 10,566 |
| Other Non-Current Liabilities | 13,722 | 16,490 | 7,788 | 0 | 8,261 |
| TOTAL | $13,944 | $16,934 | $8,807 | $N/A | $11,448 |
| Total Liabilities | $59,251 | $76,660 | $58,704 | $N/A | $53,249 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,015 | 89,977 | N/A | N/A | N/A |
| Common Shares | 11,151 | 11,113 | 10,173 | N/A | 663,785 |
| Retained earnings | -449,747 | -410,740 | -316,973 | N/A | -212,042 |
| Other shareholders' equity | 4,422 | 4,422 | 4,422 | 0 | 8,694 |
| TOTAL | $387,439 | $411,803 | $288,393 | $N/A | $460,437 |
| Total Liabilities And Equity | $446,690 | $488,463 | $347,097 | $0 | $513,685 |